Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
5.76
+0.23 (4.16%)
Nov 22, 2024, 4:00 PM EST - Market closed
Kazia Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Nov '24 Nov 22, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Market Capitalization | 25 | 7 | 26 | 58 | 128 | 32 | |
Market Cap Growth | -74.25% | -74.25% | -54.61% | -54.40% | 298.54% | 98.02% | |
Enterprise Value | 24 | 5 | 24 | 47 | 113 | 28 | |
Last Close Price | 5.76 | 2.29 | 11.60 | 42.00 | 98.60 | 33.90 | |
PS Ratio | 4.09 | 4.09 | 71609.36 | 8458.36 | 11.23 | 47.01 | |
PB Ratio | -1.02 | -1.02 | 3.30 | 4.63 | 4.50 | 3.29 | |
P/TBV Ratio | - | - | - | - | 10.76 | 27.08 | |
EV/Sales Ratio | 14.67 | 2.78 | 64547.01 | 6855.41 | 9.92 | 40.38 | |
Debt / Equity Ratio | -0.06 | -0.06 | 0.15 | 0.10 | - | - | |
Asset Turnover | 0.10 | 0.10 | 0.00 | 0.00 | 0.37 | 0.04 | |
Quick Ratio | 0.22 | 0.22 | 0.71 | 1.10 | 3.32 | 1.97 | |
Current Ratio | 0.24 | 0.24 | 1.42 | 1.40 | 3.53 | 2.10 | |
Return on Equity (ROE) | -2633.62% | -2633.62% | -134.97% | -89.14% | -32.41% | -88.05% | |
Return on Assets (ROA) | -71.60% | -71.60% | -47.18% | -33.76% | -9.82% | -34.45% | |
Return on Capital (ROIC) | -796.64% | -796.64% | -88.87% | -54.74% | -15.34% | -53.82% | |
Earnings Yield | -71.22% | -262.32% | -51.49% | -29.57% | -4.94% | -26.84% | |
FCF Yield | -24.84% | -93.86% | -38.14% | -26.91% | -5.34% | -18.97% | |
Buyback Yield / Dilution | - | -39.12% | -12.57% | -61.08% | -27.04% | |
Total Shareholder Return | - | -39.12% | -12.57% | -61.08% | -27.04% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.